Hamilton James C
Chief Medical Officer
Hamilton James C has filed 7 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Apr 24, 2026.
On the most recent filing, Hamilton James C is listed as Chief Medical Officer at ARROWHEAD PHARMACEUTICALS, INC. Inside the rolling window, Hamilton James C reported no open-market purchases and 3 open-market sales totaling $3.9M in ARWR. The largest disclosed transaction in the window is a sale of 40,164 ARWR shares on Jan 5, 2026, worth $2.5M.
Companies traded
Other insiders at ARWR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.9M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Hamilton James C made?
Hamilton James C has filed 7 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.
Which companies does Hamilton James C trade?
Hamilton James C has filed SEC Form 4 disclosures for 1 company, including ARWR.
When was Hamilton James C's most recent SEC Form 4 filing?
Hamilton James C's most recent SEC Form 4 filing on Tracefour is dated Apr 24, 2026.
What is Hamilton James C's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hamilton James C is listed as Chief Medical Officer.
What is Hamilton James C's total buy and sell value in the current window?
Inside the rolling retention window, Hamilton James C bought $0 and sold $3.9M based on SEC Form 4 filings.
What was Hamilton James C's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 40,164 ARWR shares on 2026-01-05, worth $2.5M, per SEC Form 4 filings.